Today, Kieran Robertson breaks down what he thinks about Lexaria Bioscience (LEXX.Q), a biotech that has developed a patented drug delivery technology, DehydraTECH, to improve the way active pharmaceutical ingredients are entering the bloodstream by promoting more effective oral delivery.
Lexaria Bioscience (LEXX.Q) – Three Minute Hits Video
Today, Kieran Robertson breaks down what he thinks about Lexaria Bioscience (LEXX.Q), a biotech that has developed a patented drug delivery technology, DehydraTECH, to improve the way active pharmaceutical ingredients are entering the bloodstream by promoting more effective oral delivery.
Enjoy!
Related Posts
Lexaria Bioscience (LEXX.Q) Announces Positive Results for VIRAL-A20-3 Study, Shares Climb 66%
More on LEXX.Q
Lexaria Bioscience (LEXX.Q) Announces Positive Results for VIRAL-A20-3 Study, Shares Climb 66%